Position in MDWD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$357,045
-$52,065 QoQ
Shares Held
22,163
+0.0% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDWD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MGO ONE SEVEN LLC holds $4,461,228 across 10 Biotechnology names. MDWD ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,265 | $1,457,953 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
100,000 | $696,000 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
649 | $501,443 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
7,348 | $474,901 | |
| 5 | ARGX |
Argenx SE
|
590 | $430,847 | |
| 6 | MDWD |
MediWound Ltd.
This page
|
22,163 | $357,045 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
780 | $258,078 | |
| 8 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
26,817 | $207,027 |
All Filings in MDWD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $357,045 | 22,163 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $409,110 | 22,162 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $400,206 | 22,209 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $235,577 | 12,162 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $188,754 | 12,162 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $216,412 | 12,158 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $188,692 | 12,158 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $173,251 | 12,158 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $123,646 | 12,158 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||